ASCEND BY NTHRYS
Research Abroad Products

Molecular Medicine Project Topics

Browse all focused areas across all project categories under this field.

Showing 25–36 of 200 project topics
Pharmacogenomics Testing SaaS with Clinical Integration
A white-label SaaS platform that delivers pharmacogenomic testing reports directly to healthcare providers, integrating with EHR systems to provide real-time drug-gene interaction recommendations at point of prescribing. The platform generates recurring revenue through per-test fees ($200-400), enterprise EHR integration licenses, and pharmaceutical company partnerships for precision medicine programs.
Molecular Medicine Diagnostic Platform Dev Click to view more details →
Biomarker Discovery and Validation as Commercial Service
A fee-for-service platform offering client companies access to proprietary cohorts, bioinformatics pipelines, and statistical validation for identifying and qualifying new diagnostic or prognostic biomarkers. This service model generates high-margin consulting and licensing revenue by enabling pharmaceutical, diagnostics, and life sciences companies to accelerate biomarker-driven product development.
Molecular Medicine Diagnostic Platform Dev Click to view more details →
CRISPR-Based Pathogen Detection Commercial Kit Platform
A scalable manufacturing and distribution platform for CRISPR-based molecular diagnostics kits targeting infectious diseases, food safety, and environmental monitoring with results in 30 minutes. The business model combines high-volume kit sales to hospitals and testing laboratories with licensing agreements to international distributors, targeting $50M+ annual revenue.
Molecular Medicine Diagnostic Platform Dev Click to view more details →
Molecular Profiling Dashboard for Precision Oncology
A clinical-grade SaaS dashboard that aggregates tumor genomic sequencing, RNA expression, and methylation data to provide oncologists with treatment recommendations matched to tumor molecular subtypes. The platform monetizes through per-patient analysis fees, clinical trial matching partnerships with pharma companies, and subscription models for cancer centers managing large patient cohorts.
Molecular Medicine Diagnostic Platform Dev Click to view more details →
Automated DNA Extraction and Purification System
A compact, automated benchtop system that extracts and purifies high-quality DNA from diverse sample types with 95%+ recovery rates and minimal human intervention in under 30 minutes. This hardware-software platform generates revenue through unit sales to diagnostic labs, research institutions, and forensic facilities, plus recurring revenue from proprietary consumable reagent sales.
Molecular Medicine Diagnostic Platform Dev Click to view more details →
Telomere Length Analysis Commercial Testing Service
A B2C and B2B telemedicine-integrated platform offering telomere length assessment as a biomarker for aging, disease risk, and treatment response, with personalized reports and wellness recommendations. The service generates direct-to-consumer revenue through subscription models, employer wellness programs, and clinical partnerships for aging-related research and interventions.
Molecular Medicine Diagnostic Platform Dev Click to view more details →
AI-Powered Cancer Biomarker Prediction Platform
A machine learning SaaS platform that identifies novel tumor-associated biomarkers from multi-omics datasets to enable early cancer detection. This platform generates recurring subscription revenue while reducing time-to-market for oncology diagnostic kits by 60%.
Molecular Medicine Biomarker Discovery Services Click to view more details →
Liquid Biopsy Biomarker Validation as Service
A commercial laboratory service that validates circulating tumor DNA and protein biomarkers from blood samples using proprietary mass spectrometry workflows. The service captures high-margin testing fees while establishing partnerships with pharmaceutical and diagnostic companies.
Molecular Medicine Biomarker Discovery Services Click to view more details →
Cardiovascular Disease Risk Biomarker Discovery Tool
A cloud-based analytics platform that identifies emerging cardiac biomarkers through analysis of patient cohort data to predict myocardial infarction and heart failure risk. The platform licenses to cardiology networks and insurers seeking to reduce preventable cardiac events.
Molecular Medicine Biomarker Discovery Services Click to view more details →
Neurodegenerative Disease Protein Biomarker Database
A curated, subscription-based database containing validated biomarkers for Alzheimer''s, Parkinson''s, and ALS with clinical correlations and drug development insights. This proprietary resource commands premium licensing fees from pharmaceutical companies accelerating neurological drug pipelines.
Molecular Medicine Biomarker Discovery Services Click to view more details →
Pharmacogenomic Biomarker Testing Platform SaaS
A white-label clinical testing platform that identifies genetic biomarkers predicting drug metabolism and treatment response across multiple therapeutic areas. The platform generates recurring revenue through per-test fees and integration licenses to healthcare systems and specialty pharmacies.
Molecular Medicine Biomarker Discovery Services Click to view more details →
Immune Response Biomarker Profiling Commercial Service
A laboratory service offering high-throughput immunological biomarker analysis to quantify immune checkpoint expression and predict immunotherapy response in cancer patients. The service creates differentiated revenue streams through competitive pricing and exclusive partnerships with oncology centers.
Molecular Medicine Biomarker Discovery Services Click to view more details →